Lower Margins in the Veterinary Pharmaceutical Business Due to Intensifying Competition in Eastern Japan
First written in FY2019-Q3. 2 of 4 entries say "Materialised", first in FY2019-Q3. Latest entry: 2026-10-06.
Sala moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.
The whole theme swung hardest in 2026: 40 of 87 companies on the "Worse" side.
32 other companies' latest entry also says "Worsened".
- 2026-10-06WorsenedEarnings
「利益面は、畜産及びペット関連の両部門において価格競争の激化により利益率が低下したものの、販売費及び一般管理費が減少したことから、営業損失は縮小しました。」
両部門で価格競争の激化と利益率低下が続いているが、販売費及び一般管理費の減少により営業損失は縮小した。 - FY2026-H1WorsenedAnnual report
「In terms of profit, margins declined in both the livestock and pet-related businesses due to intensifying price competition. As a result, gross profit from sales of veterinary pharmaceuticals and other products decreased, and the Company recorded an operating loss.」
従来の東日本エリアの競争激化に加え、畜産・ペット関連の両部門で価格競争の激化と利益率低下が生じ、営業損失につながった。 - 2026-04-07MaterialisedEarnings
「In the livestock business, sales declined because intense price competition meant that some government bidding projects were not selected, resulting in fewer orders. In terms of profit, in addition to the continuing impact of changes in suppliers' distribution channels in the pet-related business, margins declined amid intensifying price competition. As a result, gross profit from sales of veterinary pharmaceuticals and other products decreased, and the Company recorded an operating loss.」
The risk of intensifying competition in the veterinary pharmaceuticals business materialized in the first quarter through unsuccessful bids caused by price competition, fewer orders, and lower margins. - FY2019-Q3MaterialisedAnnual report
「利益面は東日本エリアにおいて競争環境の激化に伴い利益率が低下したことや、販売体制強化に伴う販売費及び一般管理費の増加などにより営業利益は減少しました。」
東日本エリアの競争環境激化が利益率低下および営業利益減少として実際に発生したことを、初めて独立したリスク要因として記載している。